Reactive thrombocytosis in children
The aim of this study was to evaluate the causes of thrombocytosis, which was defined as a platelet count greater than 500 x 10(9)/L, and to compare the groups with mild and severe thrombocytosis. A total of 484 patients were evaluated for the etiology of thrombocytosis. Patients with a plate...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2013-08-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/1523 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850042900432289792 |
|---|---|
| author | Celal Özcan Tülin Revide Şaylı Vildan Koşan-Çulha |
| author_facet | Celal Özcan Tülin Revide Şaylı Vildan Koşan-Çulha |
| author_sort | Celal Özcan |
| collection | DOAJ |
| description |
The aim of this study was to evaluate the causes of thrombocytosis, which was defined as a platelet count greater than 500 x 10(9)/L, and to compare the groups with mild and severe thrombocytosis. A total of 484 patients were evaluated for the etiology of thrombocytosis. Patients with a platelet count between 500-800 x 10(9)/L were considered to have mild thrombocytosis, while those with a count of ≥800 x 10(9)/L were considered as having severe thrombocytosis. Of 484 patients included, 63% had thrombocytosis due to an infectious disease, 11.4% had a chronic inflammatory condition, 8.5% had anemia, and 5.2% had tissue injury. The frequency of chronic inflammation was higher in the severe thrombocytosis group compared to the mild thrombocytosis group (p=0.006). In conclusion, severe infections and chronic inflammatory conditions should be considered in the differential diagnosis of a patient with severe thrombocytosis.
|
| format | Article |
| id | doaj-art-46bde23f78004ca1a3dff45c8013ea56 |
| institution | DOAJ |
| issn | 0041-4301 2791-6421 |
| language | English |
| publishDate | 2013-08-01 |
| publisher | Hacettepe University Institute of Child Health |
| record_format | Article |
| series | The Turkish Journal of Pediatrics |
| spelling | doaj-art-46bde23f78004ca1a3dff45c8013ea562025-08-20T02:55:23ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212013-08-01554Reactive thrombocytosis in childrenCelal Özcan0Tülin Revide ŞaylıVildan Koşan-ÇulhaDepartment of Pediatrics, Ankara Children's Hematology Oncology Training and Research Hospital, Ankara, Turkey. celalozcan01@yahoo.com.tr. The aim of this study was to evaluate the causes of thrombocytosis, which was defined as a platelet count greater than 500 x 10(9)/L, and to compare the groups with mild and severe thrombocytosis. A total of 484 patients were evaluated for the etiology of thrombocytosis. Patients with a platelet count between 500-800 x 10(9)/L were considered to have mild thrombocytosis, while those with a count of ≥800 x 10(9)/L were considered as having severe thrombocytosis. Of 484 patients included, 63% had thrombocytosis due to an infectious disease, 11.4% had a chronic inflammatory condition, 8.5% had anemia, and 5.2% had tissue injury. The frequency of chronic inflammation was higher in the severe thrombocytosis group compared to the mild thrombocytosis group (p=0.006). In conclusion, severe infections and chronic inflammatory conditions should be considered in the differential diagnosis of a patient with severe thrombocytosis. https://turkjpediatr.org/article/view/1523 |
| spellingShingle | Celal Özcan Tülin Revide Şaylı Vildan Koşan-Çulha Reactive thrombocytosis in children The Turkish Journal of Pediatrics |
| title | Reactive thrombocytosis in children |
| title_full | Reactive thrombocytosis in children |
| title_fullStr | Reactive thrombocytosis in children |
| title_full_unstemmed | Reactive thrombocytosis in children |
| title_short | Reactive thrombocytosis in children |
| title_sort | reactive thrombocytosis in children |
| url | https://turkjpediatr.org/article/view/1523 |
| work_keys_str_mv | AT celalozcan reactivethrombocytosisinchildren AT tulinrevidesaylı reactivethrombocytosisinchildren AT vildankosanculha reactivethrombocytosisinchildren |